Literature DB >> 23580889

Beta-S globin haplotypes in patients with sickle cell anemia: one approach to understand the diversity in Brazil.

Jéssika Viviani Okumura1, Clarisse Lopes de Castro Lobo, Claudia Regina Bonini-Domingos.   

Abstract

Entities:  

Year:  2013        PMID: 23580889      PMCID: PMC3621640          DOI: 10.5581/1516-8484.20130019

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN: 1516-8484


× No keyword cloud information.
Sickle cell anemia (SCA) is defined as a monogenic disease that characterizes thehomozygous state of hemoglobin S (Hb S). Hemoglobin S polymerizes under adverse conditionssuch as deoxygenation, acidosis or dehydration. Its polymers deform erythrocytes and leadto a diverse and complex pathophysiology(. Beta-S globin haplotypes (βS haplotypes) areimportant in the comprehension of the clinical diversity of SCA patients. Five haplotypes havebeen associated with different ethnic groups. They are identified at specific restriction sites andnamed according to their region of origin and prevalence: Bantu, Benin, Senegal, Arabic-Indian(Saudi) and Cameroon(. This study aimed to assess the frequencies of βS haplotypes in patientswith SCA from Rio de Janeiro State, Brazil. We analyzed DNA samples from 790 patients withsickle cell disease (SCD) and classified them according to their haplotypes through an analysisof six polymorphic sites reported by Sutton et al.(. According to these authors, haplotypes thatdo not exhibit known digestion patterns should be classified as atypical. The polymorphic sites were evaluated by polymerase chain reaction (PCR) followed by restriction fragment lengthpolymorphism (RFLP)(. Of the 790 patients, 527 had SCA with the following frequencies of genotyped βS haplotypes: 295 (56.0%) Bantu/Bantu; 128 (24.3%) Bantu/Benin; 44 (8.3%)Bantu/Atypical; 36 (6.84%) Benin/Benin; 10 (1.9%) Benin/Atypical; three (0.57%) Bantu/Cameroon; three (0.57%) Benin/Cameroon; three (0.57%) Atypical/Atypical; two (0.38%)Bantu/Saudi; two (0.38%) Bantu/Senegal and one (0.19%) Benin/Saudi. From the totalnumber of 1054 chromosomes analyzed, 769 (72.96%) were identified with the Bantu allele according to the allelic frequency evaluation; 214 (20.3%) Benin; 60 (5.7%) Atypical; six(0.57%) Cameroon; three (0.28%) Saudi and two (0.19%) Senegal. Data from genotype and allele frequencies are shown in Table 1. The high frequencies of Bantu and Benin haplotypesdemonstrate the influence of Western and South-Central African on the evolution of the Brazilian population(. We identified atypical haplotypes which may have originated due togenetic mechanisms such as gene conversions and the intense miscegenation between ethnicgroups that inhabit Rio de Janeiro State and Brazil. We emphasize the need of identifying and characterizing these genetic variations in order to better understand the clinical aspects and phenotypic diversity found in Brazilian SCD patients.
Table 1

Allelic and genotypic frequency of beta-S globin haplotypes

Haplotype βS/ βSGenotypic frequency n (%)Haplotype globin βSAllelic frequency n (%)
Total527 (100) 1054 (100)
Bantu/Bantu295 (56)Bantu769 (72.96)
Bantu/Benin128 (24.3)Benin214 (20.3)
Bantu/Atypical44 (8.3)Atypical60 (5.7)
Benin/Benin36 (6.84)Cameroon6 (0.57)
Benin/Atypical10 (1.9)Saudi3 (0.28)
Bantu/Cameroon3 (0.57)Senegal2 (0.19)
Benin/Cameroon3 (0.57)  
Atypical/Atypical3 (0.57)  
Bantu/Saudi2 (0.38)  
Bantu/Senegal2 (0.38)  
Benin/Saudi1 (0.19)  

βS: beta-S globin

Genotype Frequency: number of individuals with respective haplotype

Allele Frequency: number of chromosomes with respective haplotype

Allelic and genotypic frequency of beta-S globin haplotypes βS: beta-S globin Genotype Frequency: number of individuals with respective haplotype Allele Frequency: number of chromosomes with respective haplotype
  4 in total

Review 1.  Sickle cell disease: old discoveries, new concepts, and future promise.

Authors:  Paul S Frenette; George F Atweh
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

2.  Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes.

Authors:  M Sutton; E E Bouhassira; R L Nagel
Journal:  Am J Hematol       Date:  1989-09       Impact factor: 10.047

3.  Sickle cell disease: acute clinical manifestations in early childhood and molecular characteristics in a group of children in Rio de Janeiro.

Authors:  Isaac Lima da Silva Filho; Georgina Severo Ribeiro; Patrícia Gomes Moura; Monica Longo Vechi; Andréa Cony Cavalcante; Maria José de Andrada-Serpa
Journal:  Rev Bras Hematol Hemoter       Date:  2012

Review 4.  Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches.

Authors:  Martin H Steinberg
Journal:  ScientificWorldJournal       Date:  2008-12-25
  4 in total
  5 in total

1.  Inheritance of the Bantu/Benin haplotype causes less severe hemolytic and oxidative stress in sickle cell anemia patients treated with hydroxycarbamide.

Authors:  Jéssika V Okumura; Danilo G H Silva; Lidiane S Torres; Edis Belini-Junior; Willian M Barberino; Renan G Oliveira; Gisele C S Carrocini; Gabriela B Gelaleti; Clarisse L C Lobo; Claudia R Bonini-Domingos
Journal:  J Hum Genet       Date:  2016-03-10       Impact factor: 3.172

2.  Influence of β-Globin Haplotypes on Oxidative Stress, Antioxidant Capacity and Inflammation in Sickle Cell Patients of Chhattisgarh.

Authors:  Sanjana Bhagat; Amar Singh Thakur
Journal:  Indian J Clin Biochem       Date:  2018-01-06

3.  Sickle cell anemia: clinical diversity and beta S-globin haplotypes.

Authors:  Sandra Regina Loggetto
Journal:  Rev Bras Hematol Hemoter       Date:  2013

4.  Timed Average Mean Maximum Velocity (TAMMV) of Cerebral Blood Flow of Children and Adolescents with Sickle cell Disease: correlation with clinical and hematological profiles in country.

Authors:  Bartholomew Chukwu; Lyra Menezes; Thiago Fukuda; Jamary Filho; Marilda Goncalves
Journal:  Malawi Med J       Date:  2021-09       Impact factor: 0.875

5.  Craniofacial features of patients with sickle cell anemia and sickle cell trait.

Authors:  Matheus Melo Pithon; Láiza Michele Vieira Palmeira; Ana Angélica Leal Barbosa; Rafael Pereira; Ana Carolina Dias Viana de Andrade; Raildo da Silva Coqueiro
Journal:  Angle Orthod       Date:  2014-03-04       Impact factor: 2.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.